Inspire Medical Systems, Inc. INSP
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -7.60% | 1.62% | 12.25% | 10.49% | 10.82% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -7.60% | 1.62% | 12.25% | 10.49% | 10.82% |
| Cost of Revenue | -16.01% | -9.89% | 0.23% | -1.93% | 16.18% |
| Gross Profit | -6.01% | 3.70% | 14.37% | 12.84% | 9.86% |
| SG&A Expenses | -7.68% | 5.48% | 14.45% | 21.84% | 20.77% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.76% | 1.43% | 7.28% | 13.76% | 15.52% |
| Operating Income | 84.50% | 24.71% | 44.62% | -32.64% | -165.03% |
| Income Before Tax | 233.58% | -42.37% | 37.35% | -33.33% | -121.50% |
| Income Tax Expenses | 122.30% | 1,073.18% | -6,174.43% | 97.87% | 19.66% |
| Earnings from Continuing Operations | 108.74% | -477.47% | 286.36% | -46.30% | -136.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 108.74% | -477.47% | 286.36% | -46.30% | -136.68% |
| EBIT | 84.50% | 24.71% | 44.62% | -32.64% | -165.03% |
| EBITDA | 4,066.33% | 156.06% | 45.31% | -17.61% | -98.49% |
| EPS Basic | 108.96% | -490.76% | 298.17% | -45.31% | -136.95% |
| Normalized Basic EPS | 85.95% | -40.34% | 30.16% | -11.83% | -84.08% |
| EPS Diluted | 108.22% | -493.50% | 308.36% | -43.57% | -138.03% |
| Normalized Diluted EPS | 85.40% | -39.16% | 32.93% | -10.39% | -83.71% |
| Average Basic Shares Outstanding | -2.28% | -3.37% | -2.97% | -1.83% | -0.75% |
| Average Diluted Shares Outstanding | -1.92% | -5.31% | -4.99% | -3.37% | -2.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |